Downers Grove, IL, United States of America

Natalia A Belikova


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Natalia A Belikova in Radiation Injury Treatment

Introduction

Natalia A Belikova is an accomplished inventor based in Downers Grove, Illinois. She has made significant contributions to the field of medical science, particularly in the area of radiation injury treatment. Her innovative work focuses on the use of targeted nitroxide agents to mitigate the harmful effects of radiation.

Latest Patents

Belikova holds a patent for her invention titled "Use of targeted nitroxide agents in mitigating or treating radiation injury." This patent describes compositions and methods that are useful for free radical scavenging, specifically targeting mitochondria. The compounds she developed consist of a nitroxide-containing group linked to a mitochondria-targeting group. Notably, these compounds can be cross-linked into dimers without losing their activity. The methods outlined in her patent provide a way to prevent, mitigate, and treat damage caused by radiation by delivering these compounds to patients in effective dosages.

Career Highlights

Belikova is affiliated with the University of Pittsburgh, where she continues her research and development in the field of radiation injury treatment. Her work has garnered attention for its potential applications in medical therapies, particularly for patients exposed to harmful radiation.

Collaborations

Throughout her career, Belikova has collaborated with notable colleagues, including Peter Wipf and Jianfei Jiang. These collaborations have further enhanced her research and contributed to the advancement of her innovative ideas.

Conclusion

Natalia A Belikova's contributions to the field of radiation injury treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact patient care and treatment options in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…